Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Employee compensation and benefits
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — employee compensation and benefits.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s affordable medicines — employee compensation and benefits?
- Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — employee compensation and benefits of $13.02M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s affordable medicines — employee compensation and benefits changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s affordable medicines — employee compensation and benefits decreased by 3.8% year-over-year, from $13.54M to $13.02M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s affordable medicines — employee compensation and benefits?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s affordable medicines — employee compensation and benefits has grown at a 1.5% compound annual growth rate (CAGR), from $51.95M to $54.37M.
- What does affordable medicines — employee compensation and benefits mean?
- Reflects the total personnel-related costs, including salaries, bonuses, and benefits, allocated to the segment. Monitoring this helps evaluate labor efficiency and the cost structure required to support segment operations.